Evidence map›Paper›PMID 41122037›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025

Substitution of CH

Clea Witjaksono, Vivien Herrscher, Hannah Jobelius, Nathan Noël, Fabien Massicot, Jean-Luc Vasse, Jean-Bernard Behr, Myriam Seemann

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Clea WitjaksonoEquipe Chimie Biologique et Applications Thérapeutiques, Institut de Chimie de Strasbourg UMR 7177, Université de Strasbourg/CNRS, 4, rue Blaise Pascal, Strasbourg, 67070, France.ORCID https://orcid.org/0000-0003-4922-0402
Vivien HerrscherUniversité de Reims Champagne-Ardenne, CNRS, ICMR, Reims, 51100, France.ORCID https://orcid.org/0000-0003-0253-9643
Hannah JobeliusEquipe Chimie Biologique et Applications Thérapeutiques, Institut de Chimie de Strasbourg UMR 7177, Université de Strasbourg/CNRS, 4, rue Blaise Pascal, Strasbourg, 67070, France.ORCID https://orcid.org/0000-0003-0715-8751
Nathan NoëlUniversité de Reims Champagne-Ardenne, CNRS, ICMR, Reims, 51100, France.
Fabien MassicotUniversité de Reims Champagne-Ardenne, CNRS, ICMR, Reims, 51100, France.ORCID https://orcid.org/0000-0002-1400-6804
Jean-Luc VasseUniversité de Reims Champagne-Ardenne, CNRS, ICMR, Reims, 51100, France.ORCID https://orcid.org/0000-0003-0802-1095
Jean-Bernard BehrUniversité de Reims Champagne-Ardenne, CNRS, ICMR, Reims, 51100, France.ORCID https://orcid.org/0000-0002-8998-8806
Myriam SeemannEquipe Chimie Biologique et Applications Thérapeutiques, Institut de Chimie de Strasbourg UMR 7177, Université de Strasbourg/CNRS, 4, rue Blaise Pascal, Strasbourg, 67070, France.ORCID https://orcid.org/0000-0002-2615-1574

Funding

Centre International de Recherche aux Frontières de la Chimie/ Fondation Jean-Marie LehnFondation pour la Recherche Médicale DCM20181039536
6 · The paper itself

Abstract

IspG (also known as GcpE) is a key [4Fe-4S] metalloenzyme that catalyzes the penultimate step of the methylerythritol phosphate (MEP) pathway, a well-established target for the development of new antimicrobials. This oxygen-sensitive enzyme mediates the reductive dehydroxylation of 2-C-methyl-d-erythritol 2,4-cyclodiphosphate (MEcPP) to (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate (HMBPP), requiring electron transfer proteins to deliver two electrons needed for catalysis. To probe the mechanism of IspG and access new mechanism-based inhibitors, we synthesized a substrate analogue, monofluoromethyl-d-erythritol cyclodiphosphate, in which the natural methyl group of MEcPP is replaced by a CH

Indexed as

ErythritolFluoridesIron-Sulfur ProteinsSugar PhosphatesCatalysisErythritolFluoridesIron-Sulfur Proteinsmethyl-D-erythritol 2,4-cyclodiphosphateSugar PhosphatesinhibitorsIspG (GcpE)MEP pathwaymetalloenzymesuicide substrate

Identifiers

PMID41122037
PMCPMC12648460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.